Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 11,666 shares at $35.04 ($409K) on 2024-03-27, disclosed to the SEC on 2024-03-29.
Scheduled sale ($409k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.04 | 5,833 | $204K | 50.0% |
| 2 | $35.04 | 5,833 | $204K | 50.0% |
| Total | $35.04 avg | 11,666 | $409K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-17 | $40K | — | Filing → |
| FDMT | SELL | 2026-07-02 | $92K | — | Filing → |
| FDMT | SELL | 2026-06-25 | $118K | — | Filing → |